【医伴旅】FDA授予恩格列净突破性治疗称号,治疗射血分数保留性心力
撰稿: 医伴旅内容团队
原创文章,未经许可,请勿转载
商务合作请联系:13304614152
抓紧报名丨添加请备注:00421
参考资料:
https://www.pharmacytimes.com/view/fda-grants-breakthrough-therapy-designation-to-empagliflozin-for-heart-failure-with-preserved-ejection-fraction
赞 (0)